Sign In
Buy ZTS
$77.59
+1.20 (+1.57%)
At Close: Jun 03, 2026
Dana Investment Advisors Inc. Has $8.38 Million Stock Position in Zoetis Inc. $ZTS
05:22am, Tuesday, 24'th Feb 2026
Dana Investment Advisors Inc. reduced its holdings in Zoetis Inc. (NYSE: ZTS) by 10.2% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange
Dakota Wealth Management Decreases Position in Zoetis Inc. $ZTS
04:49am, Tuesday, 24'th Feb 2026
Dakota Wealth Management lowered its position in shares of Zoetis Inc. (NYSE: ZTS) by 9.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissio
2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $200
09:42am, Sunday, 22'nd Feb 2026
Healthcare is an evergreen industry ripe for finding fantastic dividend-growth stocks. The Wegovy pill has breathed new life into Novo Nordisk.
Alliance Wealth Advisors LLC UT Lowers Stock Position in Zoetis Inc. $ZTS
03:19am, Sunday, 22'nd Feb 2026
Alliance Wealth Advisors LLC UT trimmed its holdings in shares of Zoetis Inc. (NYSE: ZTS) by 21.5% during the undefined quarter, according to the company in its most recent Form 13F filing with the Se
Assetmark Inc. Sells 18,236 Shares of Zoetis Inc. $ZTS
04:16am, Saturday, 21'st Feb 2026
Assetmark Inc. cut its stake in Zoetis Inc. (NYSE: ZTS) by 69.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,173 sh
Zoetis Inc. $ZTS Shares Acquired by BNP PARIBAS ASSET MANAGEMENT Holding S.A.
06:20am, Friday, 20'th Feb 2026
BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its holdings in Zoetis Inc. (NYSE: ZTS) by 28.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Comm
Public Sector Pension Investment Board Boosts Holdings in Zoetis Inc. $ZTS
04:18am, Thursday, 19'th Feb 2026
Public Sector Pension Investment Board grew its position in Zoetis Inc. (NYSE: ZTS) by 12.7% during the undefined quarter, according to the company in its most recent disclosure with the Securities an
Why Zoetis (ZTS) is a Top Value Stock for the Long-Term
10:41am, Wednesday, 18'th Feb 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Mairs and Power's Strategic Moves: NVIDIA Corp Sees a -1.1% Portfolio Impact
06:12pm, Tuesday, 17'th Feb 2026
Exploring the Latest 13F Filing and Investment Strategies Mairs and Power (Trades, Portfolio) recently submitted their 13F filing for the fourth quarter of 202
Zoetis Inc. $ZTS Shares Sold by Crestwood Advisors Group LLC
05:05am, Tuesday, 17'th Feb 2026
Crestwood Advisors Group LLC reduced its position in shares of Zoetis Inc. (NYSE: ZTS) by 7.0% during the undefined quarter, according to the company in its most recent 13F filing with the Securities
Impax U.S. Sustainable Economy Fund Q4 2025 Contributors And Detractors
10:58am, Monday, 16'th Feb 2026
Eli Lilly is included due to its strategic positioning with respect to sustainability opportunities, specifically in HealthCare Access and Innovation. Advanced Micro Devices is owned for its exception
Zoetis: Why I'm Doubling Down On My Worst 2025 Pick
08:15am, Monday, 16'th Feb 2026
Zoetis is reiterated as a buy, with a 20% upside to a $159/share fair value, driven by margin expansion and a cheap valuation. ZTS delivered FY 2025 revenue of $9.5B, beating guidance, and presents ex
ABN Amro Investment Solutions Sells 6,170 Shares of Zoetis Inc. $ZTS
03:15am, Monday, 16'th Feb 2026
ABN Amro Investment Solutions lowered its holdings in shares of Zoetis Inc. (NYSE: ZTS) by 19.4% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exch
Zoetis Inc (ZTS) Q4 2025 Earnings Call Highlights: Strong Full-Year Growth Amid Competitive Pressures
04:05pm, Thursday, 12'th Feb 2026
Full-Year Revenue: $9.5 billion, 2% growth on a reported basis, 6% organic operational growth.Adjusted Net Income: $2.8 billion, 6% growth on a reported basis,
Analysts Question Zoetis' Pathway To Growth As Key Segments Slide
01:24pm, Thursday, 12'th Feb 2026
Animal health firm Zoetis Inc. (NYSE: ZTS) on Thursday reported a fourth-quarter 2025 adjusted earnings per share of $1.48. The company beat the consensus of $1.40.
